GlassScriptPhysician profile
Ricardo J Lopez
NPI 1326014481
$7,687.67
in general payments reported to CMS, 2019-2025
37 companies · $973 in 2025
The $973 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $883 · 2020: $340 · 2021: $827 · 2022: $1,117 · 2023: $669 · 2024: $2,879 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,334 · Food and Beverage: $2,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,333.98 |
| Food and Beverage | $2,186.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,333.98 | 2024-2025 | |
| Abbvie INC. | $1,171.64 | 2019-2023 | |
| Exeltis, USA INC. | $605.17 | 2019-2025 | Slynd |
| Coopersurgical, INC. | $428.63 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $377.31 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Gynesonics, INC. | $355.96 | 2021-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Meditrina | $270.93 | 2023-2025 | |
| Boston Scientific Corporation | $195.95 | 2024 | |
| Avion Pharmaceuticals | $165.09 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $161.06 | 2019-2025 | |
| Ethicon US, LLC | $148.88 | 2020-2023 | Stratafix |
| Minerva Surgical, INC | $130.95 | 2019 | |
| Biogen, INC. | $126.68 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $126.60 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $122.71 | 2019-2024 | Gardasil 9, Gardasil |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $100.14 | 2020 | |
| Pfizer INC. | $95.44 | 2021-2024 | |
| Millicent US INC | $80.33 | 2020-2025 | Femlyv, Intrarosa, Femring |
| Sumitomo Pharma America, INC. | $78.59 | 2023-2024 | Myfembree, Gemtesa |
| Allergan, INC. | $67.54 | 2019-2020 | |
| Therapeuticsmd, INC. | $67.25 | 2019-2022 | |
| Aspira Women'S Health INC | $58.39 | 2021 | |
| Organon LLC | $57.98 | 2021-2023 | |
| Amag Pharmaceuticals, INC. | $44.81 | 2019 | |
| Duchesnay USA Incorporated | $42.35 | 2019 | |
| Amgen INC. | $41.94 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $40.99 | 2021-2023 | |
| Agile Therapeutics, INC. | $34.74 | 2022 | |
| Myovant Sciences INC. | $30.96 | 2022 | |
| Vertical Pharmaceuticals, LLC | $22.10 | 2019 | |
| Shield Therapeutics INC | $19.06 | 2025 | |
| Becton, Dickinson and Company | $18.92 | 2024 | |
| Sanofi Pasteur INC. | $15.39 | 2020 | |
| Karl Storz Endoscopy-America | $14.87 | 2019 | |
| Roche Diagnostics Corporation | $11.86 | 2021 | |
| Avanos Medical | $11.61 | 2020 | |
| Daiichi Sankyo INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.